Alnylam Pharmaceuticals Inc., (ALNY) discovers, develops & commercializes therapeutics based on ribonucleic acid interference. It comes under Healthcare – Biotech sector & trades as “ALNY” ticker at Nasdaq.
ALNY favors rally in bullish weekly sequence & expect continuation against April-2025 low. It favors rally in ((3)) of III against 4.07.2025 low & pullback in 3, 7 or 11 swings offers buying opportunity.
ALNY – Elliott Wave Latest Weekly View:
It ended ((I)) at $140 high since inception in June-2025 & ((II)) pullback at $31.38 low in October-2016. Above there, it is showing nest as the part of (III) of ((III)). It placed (I) of ((III)) at $153.99 high in March-2018 & (II) at $60.27 low in December-2018. Within (III), it placed I at $242.97 high in December-2022 as diagonal & II at $141.97 low in April-2024. It placed ((1)) at $212 high, ((2)) at $117.58 low, ((3)) at $236.80 high, ((4)) at $181.65 low & ((5)) at $242.97 high. It corrected II in zigzag correction ended at 0.50 Fibonacci retracement of I.
Above April-2024 low, it gapped up with ((1)) of III that broke price channel with high momentum. It ended ((1)) of III at $304.39 high in October-2024. It ended ((2)) pullback at $205.87 low in 3 swings correction at $205.87 low on 4.07.2025. Within ((2)), it placed (A) at $229.85 low, (B) at $300.90 high & (C) at $205.87 low in blue box area. It already broke to new high in (1) & expect small upside before pullback in (2) of ((3)). We like to buy the pullback of (2) in 3, 7 or 11 swings at extreme area, when reach. Later, we expect (3) to extend higher & erase momentum divergence to confirm rally to be ((3)) towards $368.5 – $469.3 area. Alternatively, if new high comes with momentum divergence, then it can be diagonal of ((1)) in 5 swings, before correcting against April-2024 low.
Source: https://elliottwave-forecast.com/stock-market/alny-eyes-rally-toward-368-469-zone/